Whole-body Vibration Versus Aerobic Exercise on the Inflammatory Status and Hormonal Parameters Premenstrual Syndrome
NCT ID: NCT04855981
Last Updated: 2024-02-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
105 participants
INTERVENTIONAL
2021-04-15
2022-05-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Physical Activity Level, Aerobic Capacity and Dietary Habits Among a Cohort of Females With Premenstrual Syndrome
NCT04901598
Effect of Weight Reduction and Aerobic Exercise on PMS Symptoms in Obese Females
NCT05707845
Premenstrual Syndrome in Young Women With Eight Weeks of Aerobic Exercise
NCT05198115
Effect of Aquatic Exercise Versus Aerobic Exercise on Primary Dysmenorrhea and Quality of Life in Adolescent Females
NCT06129708
Effect of Aerobic Exercise on Diurnal Cortisol Pattern in Premenstrual Syndrome
NCT05507255
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
whole body vibration
the subjects will receive whole-body vibration three times per week for twelve weeks +supplementations
whole body vibration
All participants in the WBV group will perform the WBV training on a vibrating device (Confidence Vibration Plate Power Plus, China), which produces a lateral peak-to-peak oscillation. They will stand on the WBV platform with a 150° knee angle during the exposure minute. They started the training with three sets of 1 min separated by a 1-min resting period and vibration amplitude of 1 mm. They will add one set every session until they performed 10 sets of WBV. The frequency started at 20 Hz, which will be increased gradually by 2 Hz every 2 weeks +magnesium (Mg) (250 g) and vitamin B6 supplementation
supplementation
the subjects will receive magnesium (Mg) (250 g) and vitamin B6 supplementation
aerobic exercise
the subjects will receive aerobic exercise three times per week for twelve weeks+supplementations
aerobic exercise
the subjects will receive aerobic exercises+ magnesium (Mg) (250 g) and vitamin B6 supplementation
supplementation
the subjects will receive magnesium (Mg) (250 g) and vitamin B6 supplementation
supplementations
the subjects will receive supplementations three times per week for twelve weeks
supplementation
the subjects will receive magnesium (Mg) (250 g) and vitamin B6 supplementation
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
whole body vibration
All participants in the WBV group will perform the WBV training on a vibrating device (Confidence Vibration Plate Power Plus, China), which produces a lateral peak-to-peak oscillation. They will stand on the WBV platform with a 150° knee angle during the exposure minute. They started the training with three sets of 1 min separated by a 1-min resting period and vibration amplitude of 1 mm. They will add one set every session until they performed 10 sets of WBV. The frequency started at 20 Hz, which will be increased gradually by 2 Hz every 2 weeks +magnesium (Mg) (250 g) and vitamin B6 supplementation
aerobic exercise
the subjects will receive aerobic exercises+ magnesium (Mg) (250 g) and vitamin B6 supplementation
supplementation
the subjects will receive magnesium (Mg) (250 g) and vitamin B6 supplementation
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Their ages will range from 18 to 25 years.
3. Having regular menstrual cycle.
Exclusion Criteria
2. Taking any medications.
3. History of chronic disease.
4. Having any psychiatric or gynecological problems
18 Years
25 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Cairo University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Al Shaymaa Shaaban Abd El Azeim
Principale investigator. al shaymaa shaaban abd el azeim
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Al Shaymaa Shaaban Abd El Azeim
Giza, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
p.t.REC/012/003183
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.